PharmaShots | Incisive News in 3 Shots

Subscribe Now

All Posts by Date

Top 20 Biopharma M&A of 2021 by Total Deal Value

Top 20 Biopharma M&A of 2021 by Total Deal Value

January 20, 2022

Sema4 Signs a Definitive Agreement to Acquire GeneDx for ~$623M

Sema4 Signs a Definitive Agreement to Acquire GeneDx for ~$623M

January 20, 2022

Amgen’s Lumakras (sotorasib) Receives MHLW Approval for the Treatment of Advanced Non-Small Cell Lung Cancer

Amgen’s Lumakras (sotorasib) Receives MHLW Approval for the Treatment of Advanced Non-Small Cell Lung Cancer

January 20, 2022

Vera Seeks to Initiate P-III Clinical Trial of Atacicept for the Treatment of Lupus Nephritis

Vera Seeks to Initiate P-III Clinical Trial of Atacicept for the Treatment of Lupus Nephritis

January 20, 2022

ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis

ChemoCentryx’s Tavneos (avacopan) Receives EU Approval of TAVNEOS® (avacopan) for the Treatment of ANCA-Associated Vasculitis

January 20, 2022

Regeneron Reports the US FDA Acceptance of sBLA for Review of Libtayo (cemiplimab) to Treat Advanced Non-Small Cell Lung Cancer

Regeneron Reports the US FDA Acceptance of sBLA for Review of Libtayo (cemiplimab) to Treat Advanced Non-Small Cell Lung Cancer

January 20, 2022

Contact Us

First Floor, B 150, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us